Methoxymethane

Methoxymethane

SCHEMBL1824463

CC(C)(C)C(OOS(=O)(=O)c1ccccc1)c1ccccc1.COC

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.36
ALDH1A1 P00352 3/20 0.35
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 2/20 0.33
GAA P10253 1/20 0.33
PARL Q9H300 1/20 0.33
CNR2 P34972 1/20 0.32
KMT2A Q03164 2/20 0.32
HSD11B1 P28845 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
SRC P12931 1/20 0.32
PSIP1 O75475 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1826870 0.97 ALDH1A1 (0.37) HTR6ALDH1A1ATML3MBTL1TDP1
SCHEMBL1826050 0.86 TSHR (0.40) HPGDTSHR
Methoxymethane SCHEMBL1825485 0.79 MAPT (0.36) HTR6ALDH1A1TDP1MAPTLMNA
Methoxymethane SCHEMBL1825482 0.79 CCR5 (0.36) HTR6ALDH1A1TDP1MAPTLMNA
Methoxymethane SCHEMBL1825502 0.77 CYP1A2 (0.33) HTR6ALDH1A1TDP1MAPTLMNA
SCHEMBL1827608 0.76 TSHR (0.36) HTR6ALDH1A1TDP1MAPTLMNA
SCHEMBL2127629 0.75 ATM (0.41) ATML3MBTL1TSHR
SCHEMBL1825460 0.75 CCR5 (0.38) HTR6ALDH1A1TDP1MAPTLMNA
SCHEMBL16047726 0.73 ALDH1A1 (0.39) HTR6ALDH1A1ATML3MBTL1TDP1
SCHEMBL1824462 0.73 TDP1 (0.51) ALDH1A1L3MBTL1TDP1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 HTR6 3618/4885ALDH1A1 1099/4885ATM 4601/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 HTR6 4351/4885ALDH1A1 1440/4885ATM 4386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.